Perez Edith A.

Perez Edith A. serves as the Chief Medical Officer at Bolt Biotherapeutics, Inc., a company focused on innovative therapies in the healthcare sector. As of March 6, 2024, Perez has made a notable public disclosure valued at approximately $298.4K, reflecting her role in the company's strategic initiatives. This disclosure is documented through SEC Form 4 filings, highlighting her engagement with Bolt Biotherapeutics (BOLT) in the evolving landscape of biotherapeutics.